Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 11/30/15
Due: 11/30/16
Phase: N/A
Priority: Normal
Start: 04/12/19
End: 12/14/24
Due: 12/14/25
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 10/31/17
Due: 10/31/18
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer | NCT02020291 | WntResearch AB | user2@example.com | None | 2013-06-30 | 2015-11-30 | 2016-11-30 | - | - | 2025-07-14 |
| Foxy-5 as Neo-Adjuvant Therapy in Subjects With Wnt-5a Low Colon Cancer | NCT03883802 | WntResearch AB | user2@example.com | None | 2019-04-12 | 2024-12-14 | 2025-12-14 | - | - | 2025-07-14 |
| Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients | NCT02655952 | WntResearch AB | user2@example.com | None | 2016-04-30 | 2017-10-31 | 2018-10-31 | - | - | 2025-07-14 |